共 30 条
[1]
Goustin A.S., Leof E.B., Shipley G.D., Et al., Growth factors and cancer, Cancer Res, 46, pp. 1015-1029, (1986)
[2]
Clark W.H., Elder D.E., Guerry D., Et al., A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma, Hum Pathol, 15, pp. 1147-1165, (1984)
[3]
Becker D., Meier C.B., Herlyn M., Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor, EMBOJ, 8, pp. 3685-3691, (1989)
[4]
Lu C., Vickers M.F., Kerbel R.S., Interleukin 6: A fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression, Proc Natl Acad Sci USA, 89, pp. 9215-9219, (1992)
[5]
Lu C., Kerbel R.S., Interleukin 6: Transition from paracrine growth inhibitor to intracellular autocrine stimulator during human melanoma progression, J Cell Biol, 120, pp. 1281-1288, (1992)
[6]
Albino A.P., Davis B.M., Nanus D.M., Induction of growth factor RNA expression in human malignant melanoma: Markers of transformation, Cancerres, 51, pp. 4815-4820, (1991)
[7]
De Witt P.E., Moretti S., Koenders P.G., Et al., Increasing epidermal growth factor receptor expression in human melanocyte tumor progression, J Invest Dermatol, 99, pp. 168-173, (1992)
[8]
Husain Z., Fitz G.G., Wick M.M., Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma, J Invest Dermatol, 95, pp. 571-575, (1990)
[9]
Albino A.P., Nanus D.M., Mentle I.R., Analysis of Kras oncogenes in malignant melanoma and precursor lesions: Correlation of point mutations with differentiation phenotype, Oncogene, 4, pp. 1363-1374, (1989)
[10]
Stretch J.R., Gatter K.C., Ralfkiaer E., Et al., Expression of mutant p53 in melanom, Cancer Res, 51, pp. 5976-5979, (1991)